Psychiatrists Global Market Opportunities And Strategies To 2023 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global Psychiatrists market.
Reasons to Purchase
- Outperform competitors using accurate up to date demand-side dynamics information.
- Identify growth segments for investment.
- Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
- Create regional and country strategies on the basis of local data and analysis.
- Stay abreast of the latest customer and market research findings
- Benchmark performance against key competitors.
- Develop strategies based on likely future developments.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest-growing market for the Psychiatrists market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Psychiatrist market opportunities and strategies to 2023 report from the author answers all these questions and many more.
The report covers the following chapters
- Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
- Report Structure – This section gives the structure of the report and the information covered in the various sections.
- Introduction – This section gives the segmentation of the psychiatrists market by geography, by type of mental disorder and by patient type covered in this report.
- Market Characteristics – The market characteristics section of the report defines and explains the psychiatrists market. This chapter includes different goods covered in the report and basic definitions.
- Supply Chain – The supply chain section of the report defines and explains the key players in the psychiatrists industry supply chain.
- Customer Information – This chapter covers recent customers’ trends/preferences in the global psychiatrists market.
- Trends And Strategies – This chapter describes the major trends shaping the global psychiatrists market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- PESTEL Analysis – This chapter provides the market opportunity assessment using the PESTEL analysis of the global psychiatrists market.
- Global Market Size And Growth – This section contains the global historic (2015 – 2019) and forecast (2019 – 2023) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
- Regional Analysis – This section contains the historic (2015 – 2019), forecast (2019 – 2023) market value and growth and market share comparison by region.
- Segmentation – This section contains the market values (2015 - 2023) and analysis for different segments in the market.
- Global Macro Comparison – The global psychiatrists market comparison with macro-economic factors gives the psychiatrists market size, percentage of GDP, and average psychiatrists market expenditure.
- Regional Market Size and Growth – This section contains the region’s market size (2019), historic and forecast (2015 - 2023) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa).
- Competitive Landscape – This section covers details on the competitive landscape of the global psychiatrists market, estimated market shares and company profiles of the leading players.
- Key Mergers And Acquisitions – This chapter gives information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions that have shaped the market in recent years.
- Conclusions And Recommendations – This section includes conclusions and recommendations based on the findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is a significant business to be gained by competitors in the next five years.
- Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- By Type Of Mental Disorder: Alcohol Abuse Mental And Behavioral Disorders; Psychoactive Substance Use Mental And Behavioral Disorders; Schizophrenia, Schizotypal And Delusional Disorders; Mood (Anxiety And Depression) Disorders; Other Mental And Behavioral Disorders
- By Type Of Patient: Inpatient; Outpatient
- Companies Mentioned: NHS; Universal Health Services; Massachusetts General Hospital; New-York Presbyterian University Hospital; Mayo Clinic; Johns Hopkins Hospital; McLean Hospitals; Sheppard and Enoch Pratt Hospital; Menninger Clinic; Resnick Neuropsychiatric Hospital
- Countries: China, Japan, India, Australia, USA, Brazil, UK, Germany, France, Spain, Italy, Russia
- Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
- Time-series: Five years historic and forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Table of Contents
1. Psychiatrists Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
Samples
LOADING...
Executive Summary
This report describes and evaluates the global psychiatrists market. It covers two five-year periods, 2015 to 2019, termed the historic period, and 2019 through 2023, the forecast period.
The global psychiatrists market reached a value of nearly $197.0 billion in 2019, having grown at a compound annual growth rate (CAGR) of 6.0% since 2015, and is expected to grow at a CAGR of 6.9% to reach nearly $256.9 billion by 2023.
Growth in the historic period resulted from the economic growth and the rise in disposable incomes in emerging markets, government initiatives for mental health reforms, and technological advances in healthcare. Factors that negatively affected growth in the historic period were limited healthcare access in low-income countries, and social stigma associated with mental illness globally. Going forward, increasing global economic growth, private health insurance reforms, and increasing social acceptance of mental health issues will drive growth. Factors that could hinder the growth of the psychiatrists market in the future include shortages of mental health professionals and the high costs of psychiatric services.
The psychiatrists market is segmented by type of mental disorder into alcohol abuse mental and behavioral disorders, psychoactive substance use mental and behavioral disorders, schizophrenia, schizotypal and delusional disorders, mood (anxiety and depression) disorders and other mental and behavioral disorders. The other mental and behavioral disorders market was the largest segment of the psychiatrists market, accounting for $69.7 billion or 35.4% of the total in 2019. The psychoactive substance use mental and behavioral disorders segment is expected to be the fastest-growing segment going forward at a CAGR of 13.5%.
The psychiatrists market is also segmented by type of patient into inpatient and outpatient. The psychiatrists for the inpatients market was the largest segment of the psychiatrists market, accounting for $144.4 billion or 73.3% of the total in 2019. The psychiatrists for the outpatients market are expected to be the fastest-growing segment going forward at a CAGR of 12.5%.
North America was the largest psychiatrist market, accounting for 47.9% of the global market in 2019. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the psychiatrists market will be the Middle East and Africa, where growth will be at CAGRs of 11.8% and 11.2% respectively. These will be followed by Asia-Pacific and Eastern Europe, where the markets are expected to grow at CAGRs of 11.17% and 7.95% respectively.
The psychiatrists market is highly fragmented, with a large number of small players. The top 10 players in the market constituted 11.8% of the total market in 2018. Players in the market include UK National Health Service, Universal Health Services, Massachusetts General Hospital, New-York Presbyterian University Hospital, and Columbia and Cornell and Mayo Clinic, Rochester and others.
The top opportunities in the global psychiatrists market will arise in the psychiatric services for mood (anxiety and depression) disorders segment, which will gain $19.2 billion of global annual sales by 2023. The psychiatrists’ market size will gain the most in the USA at $19.1 billion. Market-trend-based strategies for the psychiatrists market include investing in the psychiatric genetics studies to improve mental health treatment methods, deploying virtual mental health counseling systems to ensure efficiencies in processes and operations and to reduce costs and putting emphasis on the quality of the treatment provided to the patients to attract more patients and increase revenue. Player-based strategies for the psychiatrists market include improving the mental health of children and the young population through the launch of mental health support teams, expanding the mental health business through strategic acquisitions and satisfying patients through improved treatment methods achieved by rigorous research.
To take advantage of the opportunities, the author recommends the psychiatry service providers to consider providing cognitive–behavioral therapy interventions, collaborate across verticals and industries to provide value-based healthcare, focus on providing treatment services and preventive and promotional activities delivered by primary care centers, and educate and create awareness programs about mental health problems.
Companies Mentioned
A selection of companies mentioned in this report includes:
- 360 Behavioral Health
- Acadia Healthcare
- Al Amal Psychiatric Complex
- Al Zahra Hospital Dubai
- Alita Care
- Ambrosia Treatment Center of Medford
- Applied Behavioral Associates, LLC
- Atar Capital
- Baillie Henderson Hospital
- Bethel Foundation
- Bournewood Health Systems
- Cambian Group's Adult Services Division
- Carolina Partners In Mental HealthCare
- Carrier Clinic
- Central Institute of Psychiatry
- Centria Autism Services
- Discovery Behavioral Health
- Denmar Specialist Psychiatrist Hospital (PTY) Ltd
- East London NHS Foundation Trust
- Forest Independent Hospital
- Graylands Hospital
- Hackensack Meridian Health
- HCA Healthcare
- Hospital Alemán
- Hospital Británico
- Hunterscraig Psychiatric Clinic
- IASIS Healthcare
- Institute of Behaviour and Allied Sciences
- Johns Hopkins Hospital
- King Faisal Specialist Hospital & Research Centre
- Kirkwood Sanatorium
- Kursk Clinical Psychiatric Hospital
- LEARN Behavioral
- Massachusetts General Hospital
- Max Planck Institute of Psychiatry
- Mayo Clinic
- McLean Hospital
- Menninger Clinic
- Mental Health and Neurosciences
- Mission Health
- National Center For Neurology and Psychiatry
- National Institute of Mental Health and Neurosciences
- New-York Presbyterian University Hospital
- Nightingale Hospital
- Passport To Adaptive Living
- Pathways Health and Community Support, LLC
- Psychiatric Clinic of General Faculty Hospital (Czech Republic)
- Psychiatric Hospital Doctor Gheorghe Preda
- Resnick Neuropsychiatric Hospital
- River Cities Capital Funds
- Seiwa Hospital
- Sheppard Pratt Health System
- St. Luke's International Hospital
- Steward Health Care
- The Center for Addiction and Mental health
- The Menninger Clinic
- The Priory
- The Royal
- The University of Tokyo Hospital
- Tokyo Metropolitan Matsuzawa Hospital
- Tokyo Saiseikai Central Hospital
- Total Spectrum
- Tyne and Wear NHS Foundation Trust
- UK NHS
- Umzimzulu Hospital
- Universal Health Services
- University of Tokyo Hospital
- Vidyasagar Institute of Mental Health and Neurosciences
- Weinberger Clinic
- Wenzhou Kangning Hospital
Methodology
LOADING...